Tag: non-compliant drug manufacturers
Import Alerts: How the FDA Blocks Drugs from Non-Compliant Manufacturers
The FDA uses Import Alerts to block drugs from non-compliant manufacturers, automatically detaining shipments without inspection. Learn how the Green List works, why Indian and Chinese suppliers are being targeted, and what manufacturers must do to stay in the U.S. market.
view morerecent posts
Discover how the FDA maintains strict quality standards for generic drugs through cGMP regulations, unannounced inspections, and rigorous testing. Learn about the five key control areas, global comparisons, and real-world impact on drug safety and affordability.
Published ON: 4 FebStatin-related liver enzyme elevations are common but rarely dangerous. Learn when to worry, when to ignore, and why stopping your statin over a lab result could put your heart at risk.
Published ON: 2 FebGeneric drugs cost far less than brand-name drugs not because ingredients are cheaper, but because labor costs are structured differently. Learn how scale, regulation, and global production shape the real cost of your prescriptions.
Published ON: 9 FebMost workplace wellness programs fail because employees don’t understand how they benefit. Learn how to educate staff with clear, personalized messaging that boosts participation, cuts costs, and builds trust.
Published ON: 1 FebTeam-based care transforms how generic drugs are prescribed by bringing together doctors, pharmacists, and nurses to improve safety, adherence, and cost savings - especially for patients with multiple chronic conditions.
Published ON: 18 Feb